Prognostic Value of Lymphovascular Invasion in Upper Urinary Tract Urothelial Carcinoma after Radical Nephroureterectomy: A Systematic Review and Meta-Analysis
Autor: | Fengju Guan, Wen Liu, Lijiang Sun, Fang-Ming Wang, Guiming Zhang |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Male
medicine.medical_specialty Funnel plot Lymphovascular invasion Clinical Biochemistry 030232 urology & nephrology Urology Review Article Cochrane Library Nephroureterectomy 03 medical and health sciences 0302 clinical medicine Genetics medicine Humans Neoplasm Invasiveness Molecular Biology Survival analysis Lymphatic Vessels lcsh:R5-920 business.industry Carcinoma Biochemistry (medical) Hazard ratio General Medicine Publication bias Survival Analysis Confidence interval Urinary Bladder Neoplasms 030220 oncology & carcinogenesis Meta-analysis Blood Vessels Female business lcsh:Medicine (General) |
Zdroj: | Disease Markers, Vol 2019 (2019) Disease Markers |
ISSN: | 1875-8630 0278-0240 |
Popis: | This study was performed to identify the prognostic impact of lymphovascular invasion (LVI) in patients with upper urinary tract urothelial carcinoma (UTUC) after radical nephroureterectomy (RNU). A systematic search in PubMed, Embase, and the Cochrane Library was performed to identify relevant studies. The outcomes of interest, including progression-free survival (PFS), cancer-specific survival (CSS), and overall survival (OS), were extracted, and the pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were used for effect size estimation. Subgroup, metaregression, and sensitivity analyses were performed to explore potential origins of heterogeneity. Publication bias was estimated by Egger’s linear regression and funnel plot. Our meta-analysis included a total of 27 studies involving 17,453 patients. The pooled HRs were statistically significant for PFS (HR=1.73, 95%CI=1.41–2.11), CSS (HR=1.87, 95%CI=1.54–2.27), and OS (HR=1.56, 95%CI=1.29–1.87), with high heterogeneity (I2=77.8%, 70.3%, and 59.2%, respectively). Four studies explored the prognostic value of LVI in patients with advanced tumor stages (T3–T4). The fixed effects model (I2=33.9%) showed that the pooled HR was 1.64 (95%CI=1.35–1.99) for CSS. Egger’s plots showed no significant publication bias (PFS: P=0.443, CSS: P=0.096, and OS: P=0.894). Our meta-analysis demonstrated that LVI is a poor prognostic factor for UTUC and is strongly associated with disease recurrence, cancer-specific mortality, and overall mortality. |
Databáze: | OpenAIRE |
Externí odkaz: |